Leadership


Management Team


Ernő Duda

Ernő Duda

Founder, President & CEO

Ernő Duda

Ernő Duda

Founder, President & CEO

Ernő Duda is founder and President of the Hungarian Biotechnology Association, a representative organization active in lobbying for the interests of its member companies and the biotechnology sector in Hungary. As a serial entrepreneur and investor, he has founded or co-founded over 20 companies operating in various industries, ranging from biotechnology, high-tech, and IT firms to e-commerce and business consultancy ventures. He has co-founded and is the Chairman of Aquincum Technology Incubator. He has also co-founded and is the Business Development Director of Creative Accelerator. By participating in the work of these incubators, he selects and mentors start-ups that has the potential to develop into successful companies, be competitive enough to enter international markets, grow quickly, and become targets of future venture capital investments.

As an Assistant Professor, his course 'Biotechnology from a Business Perspective' has been running at the University of Szeged since 2004, and Mr. Duda also teaches entrepreneurship and biotechnology at various universities in both Hungarian and English. Mr. Duda was a member of the Research and Technology Innovation Council of the National Office for Research and Technology for 6 years, a member of the Board of Trustees of the Bay Zoltán Foundation for Applied Research for 8 years, and a member of EuropaBio for 2 years. He currently sits on the Board of the Hungarian Association for Innovation. He has been awarded the Order of Merit of the Republic of Hungary for his distinguished contribution to the development of the Hungarian biotechnology industry, and was granted the Dennis Gabor Award in 2012.

Péter Krajcsi, Ph.D.

Péter Krajcsi, Ph.D.

Chief Scientific Officer

Péter Krajcsi, Ph.D.

Péter Krajcsi, Ph.D.

Chief Scientific Officer

Before joining SOLVO Biotechnology in 2002, he worked as Director of Biology at ComGenex Inc., Budapest, Hungary. He was a Senior Scientist of VirRx LLC, St. Louis, MO, USA between 2000 and 2001, and worked as Head of the Department of Molecular Cell Biology and Biochemistry at Biorex R&D Co., Veszptém, Hungary between 1998 and 1999. Before 1998, he had held various academic positions in Hungary and in the United States, including the position of Visiting Scientist at Northwestern University, Dept. of Pathology, Chicago, IL, USA and Visiting Research Associate at the Inst. for Molecular Virology and Dept. of Molecular Microbiology and Immunology, St. Louis University Medical School, St. Louis, MO, USA. Dr. Krajcsi has a Ph.D. in Molecular Cell Biology and in Biochemistry and received a Doctor of Sciences (DSc) degree from the Hungarian Academy of Sciences. He has published over 90 articles in peer-reviewed scientific journals. He is a Scientific Advisor at the Dept. of Morphology and Physiology, Faculty of Health Sciences, Semmelweis University, Budapest and at the Faculty of Information Technology, Pázmány Péter Catholic University, Budapest.

Róbert Gém

Róbert Gém

Director of Finance

Senior Management Team, Operational Management Team

Róbert Gém

Róbert Gém

Director of Finance

Senior Management Team, Operational Management Team

Róbert Gém graduated as an economist (MSc, Szent Istvan University of Godollo in 2008) and has gained a solid controlling background from different industries (Chemical, FMCG, Telco) at multinational companies in the past 10 years. He spent one year on international assignment in Amsterdam and worked in virtual teams across the globe supporting Senior Management in decision making. He joined SOLVO Biotechnology’s Finance and Operational Management Team in March 2018 as an Enterprise Resource Planning specialist implementing Maconomy ERP Software, and after a short period was appointed to Finance Director, starting in July 2018. He leads SOLVO’s Backoffice Team and coordinates internal and external Financial Reporting of the Company.

Emese Kis

Emese Kis

Scientific Director

Senior Management Team, Operational Management Team

Emese Kis

Emese Kis

Scientific Director

Senior Management Team, Operational Management Team

Dr. Kis received a Master’s Degree in Biotechnology from University of Technology and Economics of Budapest, and her Ph.D. in Biochemistry from University of Szeged. She began her career at SOLVO in 2003 as a scientist in the Research and Development Laboratory. Her focus was on development of various membrane transporter assays and she was involved in a number of scientific grants and international collaborations. From 2014 she became the Head of Production Laboratory, with overall responsibility for cell membrane preparations and assay development. She was subsequently promoted to oversee operational management of the R&D department in 2016. Since 2018 she has held the position of Scientific Director, responsible for the operation of all laboratories at senior management level. Dr. Kis has contributed to 22 peer reviewed scientific papers.

Kitti Zsák Péterné Szabó

Kitti Zsák Péterné Szabó

Director of Operational Support

Senior Management Team, Operational Management Team

Kitti Zsák Péterné Szabó

Kitti Zsák Péterné Szabó

Director of Operational Support

Senior Management Team, Operational Management Team

Kitti Zsák Péterné Szabó graduated as a Biochemical Engineer (MSc) and completed Quality Assurance Special Studies at the Budapest University of Technology and Economics. She started her career at SOLVO Biotechnology in 2008 as a scientist in the Research and Development Laboratory where she worked on the species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2). She is a certified ISO 9001 Internal Auditor and Quality Assurance Manager and she is qualified in ISO/IEC 17025 Document Management and GLP. She has joined the Quality Assurance Unit in 2013 and she became the Head of the Quality Assurance Unit in 2014. Since 2017 she has been the Director of Operational Support, therefore responsible for the operations of the export, import, procurement, quality assurance and quality control processes.

Roelof Hendrik De Wilde

Roelof Hendrik De Wilde

Sales Director and Budapest Site Head

Senior Management Team, Operational Management Team

Roelof Hendrik De Wilde

Roelof Hendrik De Wilde

Sales Director and Budapest Site Head

Senior Management Team, Operational Management Team

Roelof de Wilde received his MSc degree in Molecular Biology and Biotechnology with an orientation on management from the University of Groningen, the Netherlands. He started his professional career as Study Director at SOLVO Biotechnology, Budapest, Hungary, where his main responsibilities were conducting contract-based research in the lab on drug-membrane transporter interactions. From 2012 to 2016 he served clients in North American territory as Study Manager, during which he was responsible for close to 200 contract research studies. During this period, he designed a series of data analysis and interpretation templates to streamline internal data processing in addition to helping implement new techniques to study transporter interactions in SOLVO’s labs (including hepatocyte uptake and B-clear® assays). In 2016 his responsibilities increased with a new role as Head of the North-American team, moving into a more business oriented position. Following this and after a short transition period as Head of the European team he was promoted to Director of Sales in the end of 2017, becoming responsible for both the European and Asian-Pacific business development. Backed up by his strong technical background and experience working with clients in the pharmaceutical industry globally, he is currently managing a team of several Study- and Account Managers.

Joe Zolnerciks

Joe Zolnerciks

Vice President of Business Development

Senior Management Team, Operational Management Team

Joe Zolnerciks

Joe Zolnerciks

Vice President of Business Development

Senior Management Team, Operational Management Team

Following B.Sc. and M.Res. degrees, Joe Zolnerciks was awarded his Ph.D. in membrane protein biochemistry from Imperial College London. He held positions studying drug transporters and drug-drug interactions at the University of Washington, University of London, and University of Basel, before joining SOLVO Biotechnology in 2012 as Head of Production. In this role, he was responsible for overseeing product development and manufacture, as well as leading improvements in bioprocess development. As a result of subsequent robust growth, he joined SOLVO’s North American subsidiary in 2014 as Director of ADME-Tox Services, opening SOLVO’s West Coast US office in Seattle. In 2016, Dr Zolnerciks was promoted to his current position as Vice-President of Business Development where he oversees SOLVO’s global sales, business development, and marketing activities. He is the author of over 30 research papers, reviews, book chapters, and presentations in the field of drug transporters and drug-induced toxicity.

Zsuzsanna Gáborik

Zsuzsanna Gáborik

Head of R&D Lab

Operational Management Team

Zsuzsanna Gáborik

Zsuzsanna Gáborik

Head of R&D Lab

Operational Management Team

Zsuzsanna Gáborik received a Master’s Degree in Bioengineering from University of Technology and Economics, Budapest. She earned her Ph.D. in Cellular and Molecular Physiology at the Semmelweis University, Budapest, and started her academic carrier at Department of Physiology at the Semmelweis University. She joined SOLVO in 2011 and started working in the Business Development team, with responsibility for service and product launches and scientific sales support, and participated as an editor on SOLVO’s Transporter Book. After four years her focus changed, and she joined the Research and Development Department as a Scientific Development Manager responsible for assay development. In 2016 she took over the operational management of the R&D Laboratory, and she is currently Head of the R&D Laboratory. She has contributed to 17 peer reviewed scientific publications.  

Krisztina Herédi-Szabó

Krisztina Herédi-Szabó

Principal Scientist, ADME-Tox Services

Operational Management Team

Krisztina Herédi-Szabó

Krisztina Herédi-Szabó

Principal Scientist, ADME-Tox Services

Operational Management Team

Krisztina Herédi-Szabó, PharmD, PhD, has a degree in Pharmacy from the University of Szeged, Hungary. She has earned her PhD in the field of peptide chemistry and cell biology at Creighton University, Omaha, Nebraska, USA in 2005. She has joined Solvo Biotechnology in 2006 and started working in the field of transporter proteins. She was involved in the development of several transporter assays that are now available as products and services. She is an author of 21 scientific publications and presented her group’s work at several international conferences. Her current position is Principal Scientist, ADME-Tox Services at Solvo Biotechnology, Szeged, Hungary.

Csilla Kegyes

Csilla Kegyes

Senior Sales Manager

Operational Management Team

Csilla Kegyes

Csilla Kegyes

Senior Sales Manager

Operational Management Team

Csilla Kegyes studied Biology and Chemistry at the University of ELTE, Budapest and earned her MSc summa cum laude in 1995. She also received her Economist degree in 1997 at the University of BGF, Budapest.

Csilla Kegyes, is Senior Sales Manager at SOLVO Biotechnology since 2012 and was Business Development Manager from 2006. Csilla is now responsible for scientific support of partners and customers in Europe and is account manager of Spanish, French, German, Italian and Portuguese clients.

Nóra Kormos

Nóra Kormos

Head of Quality Assurance Unit

Operational Management Team

Nóra Kormos

Nóra Kormos

Head of Quality Assurance Unit

Operational Management Team

Nóra Kormos graduated from Budapest University of Technology and Economics as a biochemical engineer. Next to her basic studies she was interested in quality assurance, so she participated on extra courses in this topic. In 2016, during her last semester she joined to SOLVO team as a Quality Control Manager Trainee. Few months later she became a QA/QC Manager and in September 2017 she was promoted to Head of Quality Assurance Unit. As Head of the Quality Assurance Unit, she is responsible for managing the different daily tasks within the Quality Assurance Unit and for the coordination of the customer audits.

Nóra Kovács

Nóra Kovács

Head of Logistics

Operational Management Team

Nóra Kovács

Nóra Kovács

Head of Logistics

Operational Management Team

Nóra Kovács received a Master’s Degree in Geography from the University of Szeged. To change fields and widen her knowledge, she completed a B.Sc. in International economics, business and diplomacy studies at Budapest Business School. She spent over a decade in the Middle East working in the field of logistics, being recruited by multinational companies to execute logistics components of US Government and Defense projects in several countries in the region including Iraq, Lebanon, and Jordan. Upon joining SOLVO in 2018 as Head of Logistics, her role is to support SOLVO’s core operations through import and export logistics, and procurement including the management of equipment and permits.

Anita Kurunczi

Anita Kurunczi

Head of Production

Operational Management Team

Anita Kurunczi

Anita Kurunczi

Head of Production

Operational Management Team

Anita Kurunczi graduated with a degree in the field of molecular biology and physiology from the University of Szeged. As a PhD student in the Neuronal Plasticity Research Group of the Institute of Biophysics, Biological Research Centre, her research was focused on hormone-induced synaptic remodeling. Prior to joining SOLVO Biotechnology she was also involved in studies of intranasal delivery of beta-amyloid peptide, in a collaboration with an Alzheimer’s disease working group. She joined SOLVO’s Production team in 2008 and gained wide experience in the field of transporters, cell culturing, product and assay development. As Head of Production Laboratory, she is responsible for all membrane and cell line products. She is a co-author of 13 international scientific papers.

Zoltán Tímár

Zoltán Tímár

Head of the Bioanalytical Laboratory

Operational Management Team

Zoltán Tímár

Zoltán Tímár

Head of the Bioanalytical Laboratory

Operational Management Team

Zoltán Timár graduated in organic chemistry at University of Szeged in 2000, has a record of academic research at Bristol University, École Nationale Superieure de Chimie de Paris and University of Colorado at Boulder. Dr Timár has authored publications and patents, applying novel synthetic organic and analytical chemistry techniques at the Nucleic Acid Solutions Division of Agilent Technologies in Boulder, Colorado as an expert scientist. His main interest is in commercializing scientific research methods and products in the fields of pharmaceuticals and analytical sciences. His contribution to industrial research resulted in the worldwide commercialization of the TC-RNA chemistry to synthesize natural and modified RNA molecules over 100 nucleotides long. He developed analytical methodologies and software to sequence oligonucleotides. Dr. Timár is Head of the Bioanalytical Laboratory and Automation, leading a team of PhD scientists, overseeing bioanalytical and automated transporter and drug metabolism assays. Under his leadership, Solvo analytical and automation services strive to continuously develop by best laboratory practices and instrumentation and aiming to be outstanding quality, highly productive and dependable provider for Solvo customers all over the world.


Board of Directors


Dr Jean-François Le Bigot

Dr Jean-François Le Bigot is the chairman and CEO of Citoxlab Group one of the leading international non-clinical Contract Research Organisation (CRO). With 39 years’ experience in drug development, he manages 8 research sites located in 5 countries which provide a comprehensive range of pre-clinical services and specialty safety evaluation services to meet the needs of pharmaceutical, biotechnology and chemical companies worldwide.

After gaining a PhD in Biochemical Pharmacology (Université Pierre et Marie Curie, Paris, 1979), Jean-Francois Le Bigot joined Sandoz Laboratories (Novartis now) as Head of experimental biology and then Director of Pre-Clinical Development in France. He joined CIT (Centre International de Toxicologie) in 1987 as Director of Toxicology and became CEO of the company in 1992. After a first investment in Atlanbio, a CRO specializing in bioanalysis, he orchestrated the acquisition of LAB-Research Group (with facilities in Canada, Denmark and Hungary) in 2011 and became the Chairman and CEO of Citoxlab Group. Citoxlab acquired more recently Accellab (Montreal), a CRO specialized in medical devices (2016), Xenometrics (Kansas-City, 2017) and Solvo (Budapest) the leader in transport and DDI studies (2018). 
As a consequence of the development of activities, CIT then Citoxlab staff increased from 140 to 1300 between 1987 and 2018.

Patrick Spies

Patrick Spies holds a Master in corporate law from the Paris II University and a Parisian Political Science School Diploma in economics and finance.He started his professional career as a financial auditor with Arthur Andersen in Paris. Then he became Deputy Director of the Joire Pajot Martin Bank (Bearbull Group), General Services and Non-strategic Buying Director for the Hachette Filipacchi Médias Group, General Director in charge of administration and finance with SEP (Walter Marketing Group), and General Secretary of the Beauvallet Group.

He is currently Executive Vice President – General Secretary and Corporate Development for the CiToxLAB Group. The Group offers a wide range of preclinical services in response to the requirements of pharmaceutical, chemical and biotechnology companies around the world. Citoxlab performs general and reproductive toxicology, carcinogenesis, bioanalysis, immunology and safety pharmacology studies, and was formed in 2011 by the fusion of CIT and LAB-Research. The Citoxlab Group employs more than 1,300 people over eight sites (two in France, two in Canada, one in Denmark, two in Hungary and one in the USA).

Christopher Banks

Chris Banks is a Diplomat of the American Board of Toxicology. His career has spanned three decades in contract research. He worked for 12 years with LSR in the UK, prior to spending 19 years in Canada with Charles River Laboratories (formerly CTBR and Bio-Research). His roles have included Scientific Director of Inhalation Toxicology, Director of Scientific Operations and Director of Project Management, responsible for the oversight and coordination of drug development programs for current or future key clients. He joined Citoxlab, Hungary as the Managing Director in January 2008 and left in 2014 to pursue other activities, but remained an active member of the Board of Directors for Hungary and a member of the Scientific Advisory Board for the Citoxlab Group. Chris re-joined the Citoxlab Group at the end of 2017 as the Senior Vice President of Business Development, EMEA and Global Director of Inhalation Toxicology.

Ernő Duda

Ernő Duda is founder and President of the Hungarian Biotechnology Association, a representative organization active in lobbying for the interests of its member companies and the biotechnology sector in Hungary. As a serial entrepreneur and investor, he has founded or co-founded over 20 companies operating in various industries, ranging from biotechnology, high-tech, and IT firms to e-commerce and business consultancy ventures. He has co-founded and is the Chairman of Aquincum Technology Incubator. He has also co-founded and is the Business Development Director of Creative Accelerator. By participating in the work of these incubators, he selects and mentors start-ups that has the potential to develop into successful companies, be competitive enough to enter international markets, grow quickly, and become targets of future venture capital investments.

As an Assistant Professor, his course 'Biotechnology from a Business Perspective' has been running at the University of Szeged since 2004, and Mr. Duda also teaches entrepreneurship and biotechnology at various universities in both Hungarian and English. Mr. Duda was a member of the Research and Technology Innovation Council of the National Office for Research and Technology for 6 years, a member of the Board of Trustees of the Bay Zoltán Foundation for Applied Research for 8 years, and a member of EuropaBio for 2 years. He currently sits on the Board of the Hungarian Association for Innovation. He has been awarded the Order of Merit of the Republic of Hungary for his distinguished contribution to the development of the Hungarian biotechnology industry, and was granted the Dennis Gabor Award in 2012.